UWSpace is currently experiencing technical difficulties resulting from its recent migration to a new version of its software. These technical issues are not affecting the submission and browse features of the site. UWaterloo community members may continue submitting items to UWSpace. We apologize for the inconvenience, and are actively working to resolve these technical issues.
 

Could The Human Papillomavirus Vaccines Drive Virulence Evolution?

dc.contributor.authorMurall, Carmen Lia
dc.contributor.authorBauch, Chris T.
dc.contributor.authorDay, Troy
dc.date.accessioned2018-09-21T12:30:15Z
dc.date.available2018-09-21T12:30:15Z
dc.date.issued2015-01-07
dc.descriptionDefinitive version as published available at: Full Cite, http://dx.doi.org/10.1098/rspb.2014.1069en
dc.description.abstractThe human papillomavirus (HPV) vaccines hold great promise for preventing several cancers caused by HPV infections. Yet little attention has been given to whether HPV could respond evolutionarily to the new selection pressures imposed on it by the novel immunity response created by the vaccine. Here, we present and theoretically validate a mechanism by which the vaccine alters the transmission-recovery trade-off that constrains HPV's virulence such that higher oncogene expression is favoured. With a high oncogene expression strategy, the virus is able to increase its viral load and infected cell population before clearance by the vaccine, thus improving its chances of transmission. This new rapid cell-proliferation strategy is able to circulate between hosts with medium to high turnover rates of sexual partners. We also discuss the importance of better quantifying the duration of challenge infections and the degree to which a vaccinated host can shed virus. The generality of the models presented here suggests a wider applicability of this mechanism, and thus highlights the need to investigate viral oncogenicity from an evolutionary perspective.en
dc.description.sponsorshipCIHRen
dc.identifier.urihttp://dx.doi.org/10.1098/rspb.2014.1069
dc.identifier.urihttp://hdl.handle.net/10012/13882
dc.language.isoenen
dc.publisherRoyal Society, Theen
dc.subjecthuman papillomavirusen
dc.subjectvirulence evolutionen
dc.subjectoncogenesen
dc.subjecttransmission-recovery trade-offen
dc.subjectwithin-host modelen
dc.titleCould The Human Papillomavirus Vaccines Drive Virulence Evolution?en
dc.typeArticleen
dcterms.bibliographicCitationDefinitive version as published available at: Murall, C. L., Bauch, C. T., & Day, T. (2014). Could the human papillomavirus vaccines drive virulence evolution? Proceedings of the Royal Society B: Biological Sciences, 282(1798), 20141069–20141069. doi:10.1098/rspb.2014.1069, http://dx.doi.org/10.1098/rspb.2014.1069en
uws.contributor.affiliation1Faculty of Mathematicsen
uws.contributor.affiliation2Applied Mathematicsen
uws.peerReviewStatusRevieweden
uws.scholarLevelFacultyen
uws.typeOfResourceTexten
uws.typeOfResourceTexten

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ProcB_ManuscriptFINALrevision_fulldoc_clean.pdf
Size:
1.45 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.46 KB
Format:
Plain Text
Description: